Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-26-009251
Filing Date
2026-03-06
Accepted
2026-03-06 21:28:12
Documents
1
Period of Report
2026-03-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4023
  Complete submission text file 0001493152-26-009251.txt   5430
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Issuer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5895 BLAZING STAR LANE SAN DIEGO CA 92130
Business Address
Hoffman Beth J. (Reporting) CIK: 0001885321 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40943 | Film No.: 26733013